ArticleCancer research communications2026

Gustave Roussy Immune Score Validation in Patients Treated with Bispecific CD3 T-cell Engagers in Phase I Clinical Trials.

Noé Herbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.